Chemoinformaics analysis of 24-Methyl-31-Nor-Lanost-9(11)-En-3-Beta-Ol
| Molecular Weight | 440.756 | nRot | 4 |
| Heavy Atom Molecular Weight | 388.34 | nRig | 21 |
| Exact Molecular Weight | 440.402 | nRing | 4 |
| Solubility: LogS | -6.977 | nHRing | 0 |
| Solubility: LogP | 8.739 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 84 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 32 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 52 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 31 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 87.2452 |
| nHD | 1 | BPOL | 52.1668 |
| QED | 0.433 |
| Synth | 4.748 |
| Natural Product Likeliness | 3.3 |
| NR-PPAR-gamma | 0.098 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.344 |
| Pgp-sub | 0 |
| HIA | 0.005 |
| CACO-2 | -4.878 |
| MDCK | 0.0000116 |
| BBB | 0.088 |
| PPB | 0.95814 |
| VDSS | 2.671 |
| FU | 0.015301 |
| CYP1A2-inh | 0.049 |
| CYP1A2-sub | 0.35 |
| CYP2c19-inh | 0.098 |
| CYP2c19-sub | 0.96 |
| CYP2c9-inh | 0.172 |
| CYP2c9-sub | 0.368 |
| CYP2d6-inh | 0.088 |
| CYP2d6-sub | 0.219 |
| CYP3a4-inh | 0.515 |
| CYP3a4-sub | 0.681 |
| CL | 13.965 |
| T12 | 0.014 |
| hERG | 0.096 |
| Ames | 0.001 |
| ROA | 0.317 |
| SkinSen | 0.416 |
| Carcinogencity | 0.026 |
| EI | 0.137 |
| Respiratory | 0.815 |
| NR-Aromatase | 0.271 |
| Antiviral | No |
| Prediction | 0.549733 |